Healthpeak Properties (NYSE:DOC) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Healthpeak Properties (DOC) from a "hold" to a "sell," joining other recent analyst cuts and price-target reductions; the consensus remains a Hold with an average price target of $19.42.
• Healthpeak beat Q4 estimates with $0.47 EPS (vs. $0.45) and $719.4M revenue, and set FY2026 guidance of 1.700–1.740 EPS versus analysts' average 1.86, while the stock opened at $16.54 and was down about 1.5%.
• Institutional investors own 93.57% of the shares, with large funds such as State Street, JPMorgan, Fuller & Thaler and Invesco notably increasing their stakes recently.

Healthpeak Properties (NYSE:DOC - Get Free Report) was downgraded by Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Saturday.

Several other analysts also recently weighed in on DOC. Jefferies Financial Group downgraded Healthpeak Properties from a "buy" rating to a "hold" rating and lowered their price objective for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Wells Fargo & Company restated a "positive" rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Weiss Ratings raised shares of Healthpeak Properties from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Monday, January 26th. Evercore lowered their price target on shares of Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, February 4th. Finally, The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They set a "neutral" rating and a $17.00 price target for the company. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties presently has an average rating of "Hold" and an average price target of $19.42.

Healthpeak Properties Stock Down 1.5%

Shares of NYSE:DOC opened at $16.54 on Friday. The stock's 50-day moving average price is $17.21 and its 200-day moving average price is $17.51. Healthpeak Properties has a 12-month low of $15.71 and a 12-month high of $20.40. The stock has a market capitalization of $11.50 billion, a P/E ratio of 165.45, a price-to-earnings-growth ratio of 8.99 and a beta of 1.12. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping the consensus estimate of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company's quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current year.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently made changes to their positions in the business. State Street Corp boosted its holdings in Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock valued at $947,889,000 after acquiring an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock worth $493,251,000 after purchasing an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust's stock worth $312,959,000 after purchasing an additional 123,274 shares during the period. Finally, Invesco Ltd. lifted its position in shares of Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust's stock worth $294,244,000 after purchasing an additional 1,648,012 shares during the period. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.